NIH-funded research U01 cooperative agreement

SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers

Official title: StAtins Use in intRacereberal hemorrhage patieNts MRI (SATURN MRI) Ancillary Study

Funded at Beth Israel Deaconess Medical Center · NIH-11625633 · Data updated 2026-11-12

This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 15, 2021
Project endAugust 31, 2027
Funding year2026
Award (this year)$68,553
NIH project number3U01NS120871-03S3
Project IDNIH-11625633 on NIH RePORTER

Who could benefit from this research

Could help

Adults with lobar intracerebral hemorrhage who are taking statins and are enrolled in the SATURN trial.

Less likely to help

Individuals not receiving statins or those without lobar ICH or not part of SATURN-related procedures.

What this research studies

If you had a lobar intracerebral hemorrhage and are on a statin, this ancillary MRI study will follow you with brain scans at the start and after about two years to see how statin use affects small vessel disease markers like microbleeds. It is built on the SATURN trial framework and uses a pragmatic, open-label design with blinded outcome assessment to explore safety and potential benefits of continuing statins. The researchers will compare ongoing statin therapy versus discontinuation and examine correlations between MRI findings and future risk of bleeding or other health events. The goal is to help personalize decisions about statin therapy for people who have had a lobar ICH and are at risk for recurrence.

Why it matters

Potential benefit: If successful, findings could guide safer, more effective use of statins in people with lobar ICH and inform imaging-based risk stratification.

How similar studies have gone: This is a continuation of SATURN; prior data are limited and the ancillary MRI study aims to add novel imaging insights.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Selim, Magdy H — Beth Israel Deaconess Medical Center
  • Study coordinator: Selim, Magdy H

Related research

Other NIH-funded projects on the same topics.

  • Wearable tech to track blood loss during childbirth

    A wearable device monitors cardiovascular signals to detect postpartum hemorrhage early so clinicians can act quickly to protect mothers.

    NIH research Washington University · Saint Louis, United States · NIH-11627926

  • Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study

    This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625632

  • Statin use after brain bleed: SATURN MRI ancillary study

    This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625628

  • Maternal Postpartum Monitoring with a Wearable Sensor (MOMS)

    A wearable system called MOMS will continuously monitor multiple physiological signals in pregnant people to detect postpartum hemorrhage earlier than standard vital signs.

    NIH research University of California-Irvine · Irvine, United States · NIH-11536966

  • Anticoagulation in ICH Survivors with Atrial Fibrillation and Small Vessel Disease

    This project looks at how to safely use blood-thinning medicines in people who survived a brain bleed and also have atrial fibrillation and small vessel disease.

    NIH research Yale University · New Haven, United States · NIH-11533213

  • Statin use after lobar intracerebral hemorrhage

    This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518526

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.